Bessemer Group Inc. grew its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ: COLL) by 48.

BOSTON--(BUSINESS WIRE)--DivcoWest, a DivCore Capital company and national commercial real estate in

STOUGHTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) a

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech

BBCP, KUBTY, ADM, COLL and W have been added to the Zacks Rank #1 (Strong Buy) List on July 6, 2026.

COLL gains momentum as strong Jornay PM growth and the Azstarys acquisition boosted 2026 guidance, s

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

STOUGHTON, Mass. , June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) t

STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) tod

- Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegi

Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call Transcript

The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.76 per share, beating the Zac

– Generated Quarterly Net Revenues of $193.5 Million, Up 9% Year-over-Year –  – Generated JORNAY PM

Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for

STOUGHTON, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) t

Collegium Pharmaceutical (NASDAQ: COLL) outlined its 2026 outlook and discussed its planned acquisit

  During Thursday, 849 stocks hit new 52-week lows.

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e